CRD-103

N/A

Report date: 2023/02/04 20:21:33
NME

Base Information

Drug NameCRD-103
Drug Alias NameCRD-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvacta Group PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvacta Group PLC
Active IndicationsN/A
Inactive IndicationsBipolar Disorder

Other Information

ATC CodeN/A
Related LinksN/A